Louis School of Medicine. He completed his pharmacy studies, M.Sc. in medicinal chemistry and Ph.D. in pharmaceutical sciences focusing on targeted drug delivery to cancer at the Hebrew University of Jerusalem, and a post doctoral training focusing on cancer cell biology at Harvard Medical School. Dr. Azab achieved several national and international awards, and published more than 40 peer reviewed articles, a book chapter and 4 patents. He serves as a senior editor of the American Journal of Cancer Biology, and a reviewer for many other journals.